These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2357862)

  • 1. Phenylpropanolamine increases plasma caffeine levels.
    Lake CR; Rosenberg DB; Gallant S; Zaloga G; Chernow B
    Clin Pharmacol Ther; 1990 Jun; 47(6):675-85. PubMed ID: 2357862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent response to phenylpropanolamine: inhibition of orthostasis.
    Lake CR; Rosenberg DB; Gallant S; Zaloga G; Chernow B
    J Clin Pharmacol; 1991 Jul; 31(7):624-35. PubMed ID: 1894758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacodynamic interaction between caffeine and phenylpropanolamine.
    Brown NJ; Ryder D; Branch RA
    Clin Pharmacol Ther; 1991 Oct; 50(4):363-71. PubMed ID: 1914371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of phenylpropanolamine on human sympathetic nervous system function.
    Lake CR; Chernow B; Zaloga G; Labow J; Quirk R; Hedges SM
    Neuropsychopharmacology; 1988 May; 1(2):163-8. PubMed ID: 3251497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient hypertension after two phenylpropanolamine diet aids and the effects of caffeine: a placebo-controlled follow-up study.
    Lake CR; Zaloga G; Bray J; Rosenberg D; Chernow B
    Am J Med; 1989 Apr; 86(4):427-32. PubMed ID: 2929629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of blood pressure, heart rate and behavioral mood state to norepinephrine kinetics in younger and older men following caffeine ingestion.
    Arciero PJ; Gardner AW; Benowitz NL; Poehlman ET
    Eur J Clin Nutr; 1998 Nov; 52(11):805-12. PubMed ID: 9846593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double dose of phenylpropanolamine causes transient hypertension.
    Lake CR; Zaloga G; Clymer R; Quirk RM; Chernow B
    Am J Med; 1988 Sep; 85(3):339-43. PubMed ID: 3414729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual variability in the blood pressure response to intravenous phenylpropanolamine: a pharmacokinetic and pharmacodynamic investigation.
    O'Connell MB; Pentel PR; Zimmerman CL
    Clin Pharmacol Ther; 1989 Mar; 45(3):252-9. PubMed ID: 2920500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic interactions between phenylpropanolamine, caffeine and chlorpheniramine in rats.
    Kaddoumi A; Nakashima MN; Wada M; Nakashima K
    Eur J Pharm Sci; 2004 Jun; 22(2-3):209-16. PubMed ID: 15158906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of caffeine on blood pressure response during exercise in normotensive healthy young men.
    Sung BH; Lovallo WR; Pincomb GA; Wilson MF
    Am J Cardiol; 1990 Apr; 65(13):909-13. PubMed ID: 2321541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use.
    Haller CA; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2002 Jun; 71(6):421-32. PubMed ID: 12087345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dispositional factors do not contribute to the enantiospecificity of the cardiovascular effects of phenylpropanolamine.
    Stockley CS; Wing LM; Tonkin AL; Miners JO
    Clin Pharmacol Ther; 1994 Jan; 55(1):35-43. PubMed ID: 8299314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism between caffeine and dl-phenylpropanolamine on brown adipose tissue thermogenesis in the adult rat.
    Wellman PJ; Marmon MM
    Pharmacol Biochem Behav; 1985 May; 22(5):781-5. PubMed ID: 4011637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathomimetic effects of paraxanthine and caffeine in humans.
    Benowitz NL; Jacob P; Mayan H; Denaro C
    Clin Pharmacol Ther; 1995 Dec; 58(6):684-91. PubMed ID: 8529334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the potential for pharmacodynamic and pharmacokinetic drug interactions between selegiline transdermal system and two sympathomimetic agents (pseudoephedrine and phenylpropanolamine) in healthy volunteers.
    Azzaro AJ; VanDenBerg CM; Ziemniak J; Kemper EM; Blob LF; Campbell BJ
    J Clin Pharmacol; 2007 Aug; 47(8):978-90. PubMed ID: 17554106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of urine pH modification on the pharmacokinetics and pharmacodynamics of phenylpropanolamine.
    Zimmerman CL; O'Connell MB; Soria I
    Pharm Res; 1990 Jan; 7(1):96-102. PubMed ID: 2300545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled clinical trial of the cardiovascular and psychological effects of phenylpropanolamine and caffeine.
    Noble R
    Drug Intell Clin Pharm; 1988 Apr; 22(4):296-9. PubMed ID: 3286173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phenylpropanolamine and isometric exercise on blood pressure.
    Pentel PR; Eisen T
    Int J Obes; 1988; 12(3):199-204. PubMed ID: 3391736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine.
    Haller CA; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2004 Apr; 75(4):259-73. PubMed ID: 15060505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral hemorrhage associated with phenylpropanolamine in combination with caffeine.
    Mueller SM; Muller J; Asdell SM
    Stroke; 1984; 15(1):119-23. PubMed ID: 6695415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.